The Federal NOPAIN Act

TKG PACT Executive Briefings - 3-Minute Market Insights

Content provided by The Kinetix Group, Powered by Petauri, The Kinetix Group, and Powered by Petauri. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by The Kinetix Group, Powered by Petauri, The Kinetix Group, and Powered by Petauri or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

2M ago 3:19

MP3•Episode home

Send us a text

Today’s topic is the The Federal NOPAIN Act.

The Federal “Non-Opioids Prevent Addiction In the Nation Act” (or, the “NOPAIN Act”), Senate bill S.586, was signed into law in December 2022. It takes effect this coming January as part of the Centers for Medicare and Medicaid Services 2025 OPPS proposed rule.

The NOPAIN Act directs CMS to reimburse hospital and surgical centers separately for non-opioid, post-surgical pain control, in hopes of reducing or replacing opioid consumption. By separating, or “unbundling,” payment for non-opioid pain control, hospitals and surgical centers may receive additional reimbursement for non-opioid alternatives, encouraging the use of substitute means of pain control. This helps to ensure that non-opioid options are more widely available to individuals as a post-surgical treatment option.
You can download the full Executive Briefing at: https://tkgpact.com/executive-briefings/

Or, feel free to email us at Insights@thekinetixgroup.com

58 episodes

#Fitness #Medicine #The Kinetix Group #Healthcare #Pharma #Voice #Triple Aim #Biotech #Health Management #Science #Alternative Health #Biology #Insight